Carboplatin alone (C) vs. carboplatin + high-dose epirubicin (HDCE) + growth-factors (GF) in late recurrences ovarian cancer patients (PTS). - Bolis,G.; Brusati,M.; Ferraris,A. (Proc Am Soc Clin Oncol, 1994)